Effects of estrogen and androgen deprivation on the progression of non-alcoholic steatohepatitis (NASH) in male Sprague - Dawley rats

Hepatology Research

Volumn 39, Issue 9, 2009, Pages 910-920

  Mu, Yanjun ^a   She, Ruiping ^a   Zhang, Hua ^a   Dong, Bing ^a   Huang, Chengfei ^a   Lin, Wei ^a   Li, Defa ^a   Li, Xiangdong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Androgen; Estrogen; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANDROGEN; CHOLESTEROL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FAS ANTIGEN; FLUTAMIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TAMOXIFEN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 2;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; ESTROGEN ACTIVITY; HISTOPATHOLOGY; HORMONE INHIBITION; LIPID BLOOD LEVEL; LIPID DIET; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

EID: 69949096681     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00512.x     Document Type: Article

References (40)

1. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 1994; 107: 1103-9.
2. Matteoni C, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-19.
3. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002 Nov; 123: 1705-25.
4. James O, Day C. Non-alcoholic steatohepatitis: Another disease of affluence. Lancet 1999 (May 15); 353: 1634-6.
5. Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP. Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol 2007 Feb; 102: 399-408.
6. Cheung O, Kapoor A, Puri P et al. The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. Hepatology 2007 Oct; 46: 1091-100.
7. Mendelsohn ME. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002; 89: 12E-7E; discussion 7E-8E.
8. Hewitt KN, Pratis K, Jones ME, Simpson ER. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology 2004; 145: 1842-8.
9. Jones M, Thorburn A, Britt K. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 2000; 97: 12735-40.
10. Smith EP, Boyd J, Frank GR et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331: 1056-61.
11. Maffei L, Murata Y, Rochira V et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: Effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 2004 Jan; 89: 61-70.
12. Fan JG, Zhu J, Li XJ et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005 Sep; 43: 508-14.
13. Browning JD, Szczepaniak LS, Dobbins R et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004 Dec; 40: 1387-95.
14. Nemoto Y, Saibara T, Ogawa Y et al. Tamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen. Intern Med 2002 May; 41: 345-50.
15. Nishino M, Hayakawa K, Nakamura Y, Morimoto T, Mukaihara S. Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: High frequency of involvement and rapid reversal after completion of tamoxifen therapy. AJR Am J Roentgenol 2003 Jan; 180: 129-34.
16. Lubahn D, Moyer J, Golding T, Couse J, Korach K, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 1993; 90: 11162-6.
17. Couse JF, Hewitt SC, Bunch DO et al. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science 1999; 286: 2328-31.
18. Dieudonne MN, Pecquery R, Boumediene A, Leneveu MC, Giudicelli Y. Androgen receptors in human preadipocytes and adipocytes: Regional specificities and regulation by sex steroids. Am J Physiol 1998 Jun; 274: C1645-52.
19. Boyanov MA, Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 2003 Mar; 6: 1-7.
20. Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006 Jun; 154: 899-906.
21. Fan W, Yanase T, Nomura M et al. Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 2005 Apr; 54: 1000-8.
22. Sato T, Matsumoto T, Yamada T, Watanabe T, Kawano H, Kato S. Late onset of obesity in male androgen receptor-deficient (AR KO) mice. Biochem Biophys Res Commun 2003 (Jan 3); 300: 167-71.
23. Lin HY, Yu IC, Wang RS et al. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology 2008 Jun; 47: 1924-35.
24. Morizono S, Nakamuta M, Ohta S et al. [Case of NASH exacerbated after testectomy due to seminoma]. Fukuoka Igaku Zasshi 2004 Jun; 95: 146-51.
25. Boisvert W, Black A, Curtiss L. ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages. Arterioscler Thromb Vasc Biol 1999 Mar; 19: 525-30.
26. Li X, Nokkala E, Yan W et al. Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 2001 Jun; 142: 2435-42.
27. Sambrook J, Russel D. Recovery of DNA from Agarose gels: Electrophoresis onto DEAE-cellulose membranes. In: Molecular Cloning: A Laboratory Manual, 3rd edn. New York, Cold Spring Harbor Laboratory Press, 2001; 518-22.
28. Li X, Strauss L, Kaatrasalo A et al. Transgenic mice expressing p450 aromatase as a model for male infertility associated with chronic inflammation in the testis. Endocrinology 2006 Mar; 147: 1271-7.
29. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997 (Feb 18); 94: 1441-6.
30. Sanchez-Vives MV, Slater M. From presence to consciousness through virtual reality. Nat Rev Neurosci 2005 Apr; 6: 332-9.
31. Ogawa Y, Murata Y, Nishioka A, Inomata T, Yoshida S. Tamoxifen-induced fatty liver in patients with breast cancer. Lancet 1998 (Mar 7); 351: 725.
32. Lelliott CJ, Lopez M, Curtis RK et al. Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis. FASEB J 2005 Jul; 19: 1108-19.
33. Larosche I, Letteron P, Fromenty B et al. Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver. J Pharmacol Exp Ther 2007 May; 321: 526-35.
34. Naugler WE, Sakurai T, Kim S et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007 (Jul 6); 317: 121-4.
35. Chavin KD, Yang S, Lin HZ et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 1999 (Feb 26); 274: 5692-700.
36. Baffy G, Zhang CY, Glickman JN, Lowell BB. Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 2002 Apr; 35: 753-61.
37. Starkel P, Sempoux C, Leclercq I et al. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol 2003 Oct; 39: 538-46.
38. Sanyal AJ, Campbell-Sargent C, Mirshahi F et al. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001 Apr; 120: 1183-92.
39. Brady LJ, Brady PS, Romsos DR, Hoppel CL. Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob/ ob) mice. Biochem J 1985 (Oct 15); 231: 439-44.
40. Yu HP, Yang S, Choudhry MA, Hsieh YC, Bland KI, Chaudry IH. Mechanism responsible for the salutary effects of flutamide on cardiac performance after trauma-hemorrhagic shock: Upregulation of cardiomyocyte estrogen receptors. Surgery 2005 Jul; 138: 85-92.